Cartalax is a short bioregulatory peptide material associated with cartilage and connective-tissue research. Proposed mechanisms are studied mainly in cellular and tissue models and are not defined by one well-established receptor pathway.

Its effects are being studied in relation to:
• bioregulation of cartilage and connective tissues
• improved joint regeneration
• slowing of cartilage ageing

Variant: 20 mg

For laboratory and research purposes only. Not intended for use in humans or animals.

Preparation information: follow the specification stated for this product and the relevant diluent information shown on the product page.

For laboratory and research use only. Not intended for use in humans or animals.

1. Dry powder / lyophilised material (-20 °C):
For long-term storage, keep the original unopened vial at approximately -20 °C, protected from light and moisture. For many lyophilised peptides and proteins, properly stored material may remain stable for approximately 12 to 24 months, and sometimes longer. The exact period depends on the specific compound, purity and batch documentation.

2. After reconstitution (2–8 °C):
If the compound is compatible with the selected diluent, store the reconstituted solution generally at 2–8 °C, protect it from light and do not freeze. For many peptide solutions, approximately 3 to 4 weeks is used as a practical in-use period, but this is not a universal stability guarantee. Microbiological safety depends on the diluent used and aseptic handling.

Always follow the specific storage requirements for the compound and the documentation for the particular batch.